Functional Studies of Erythrocyte Dematin
Functional Studies of Erythrocyte Dematin
批准号:
7679798
负责人:
Athar H. Chishti
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-12-01 至 2009-08-31
关键词:
ActinsAnemiaBindingBinding ProteinsBiochemicalBiological AssayBlood - brain barrier anatomyBlood PlateletsBrainCell membraneCell physiologyCellsComplexCrystalline LensCytoplasmic TailDataDefectDependenceDouble EffectEndopeptidasesEpithelialErythrocyte MembraneErythrocytesErythroid CellsEvaluationFaceFibroblastsGlucoseGlucose TransporterGlycophorin CHepatocyteHomeostasisHomologous GeneHumanHuman CharacteristicsImmunoprecipitationIntegral Membrane ProteinKnockout MiceLabelLinkMaintenanceMammalian CellMeasuresMechanicsMediatingMembraneMembrane ProteinsModelingMolecularMusMutationMyocardiumNaturePatternPeptide HydrolasesPeripheralPersonal SatisfactionPhenotypePhosphorylationPhysiologicalPropertyProteinsProteomicsRecombinant ProteinsRegulationReportingRetinaRoleSeriesShapesSiteSkeletonSpectrinStagingSurfaceSyndromeTailTestingTissuesVesicleadducinbaseexpectationglucose transportnovelpolypeptideprotein 4.1receptorreconstitutionresearch study
中文摘要
公认的是,“血影蛋白-肌动蛋白连接”在功能上是必需的。
维持红细胞膜的稳定性和机械性能。现行
范例是“血影蛋白-肌动蛋白连接”通过一个连接到质膜上。
蛋白4.1和血型糖蛋白C之间的相互作用。根据我们最近的研究结果,我们提出了一个
“血影蛋白-肌动蛋白连接”与质膜垂直连接的替代模型。
我们目前的模型预测,dematin,与内收蛋白,组装一个新的,
血影蛋白多肽末端的细胞骨架复合物,连接血影蛋白-肌动蛋白
通过跨膜蛋白连接到质膜。在这次竞争激烈的续约中,
以下实验方法将用于验证我们的假设:(1)组合
小鼠dematin和adducin的缺失导致具有高度脆性红细胞的严重贫血。
为了阐明减弱血影蛋白-肌动蛋白连接到质膜的机制,我们
将研究肌动蛋白原丝的状态,拯救膜不稳定性缺陷,检查
双突变对已知垂直相互作用的影响,并测试dematin的直接结合
内收蛋白及其通过磷酸化和寡聚化的调节。(2)Dematin绑定到
红细胞质膜上的蛋白酶敏感位点。为了识别这种蛋白质,我们将
进行细胞表面标记、免疫沉淀、蛋白质下拉测定,以及
红细胞膜囊泡的蛋白质组学分析。将进行类似的分析,
内收蛋白这些实验很可能揭示新的跨膜蛋白,
连接复合物与质膜的连接。(3)根据目标2中概述的战略,我们
在dematin免疫沉淀物中检测到50 kDa的红细胞表面蛋白。进一步
分析表明,这种蛋白质是葡萄糖转运蛋白1(GLUT-1),一种主要的跨膜转运蛋白,
红细胞膜的受体。我们建议描述的生化性质,
人dematin和adducin与GLUT-1的相互作用,鉴定相互作用的结构域,和
证明了非红细胞系细胞中新桥的保守性。自从dematin,内收蛋白,
和GLUT-1广泛表达,包括大脑,拟议的研究可能是
这对于理解脑血管病患者血脑屏障葡萄糖转运的分子基础具有重要意义。
正常和病理情况下,如GLUT-1缺乏综合征。
英文摘要
It is well recognized that the "spectrin-actin junctions" are functionally essential for the
maintenance of erythrocyte membrane stability and mechanical properties. The prevailing
paradigm is that the "spectrin-actin junctions" are linked to the plasma membrane via an
interaction between protein 4.1 and glycophorin C. Based on our recent findings, we propose an
alternate model for the vertical linkage of "spectrin-actin junctions" to the plasma membrane.
Our current model predicts that dematin, in conjunction with adducin, assembles a novel
cytoskeletal complex at the tail ends of spectrin polypeptides that links the ¿spectrin-actin
junctions¿ to the plasma membrane via a transmembrane protein. In this competitive renewal,
the following experimental approaches will be used to validate our hypothesis: (1) Combined
deletion of mouse dematin and adducin results in severe anemia with highly fragile erythrocytes.
To elucidate the mechanism of weakened spectrin-actin linkage to the plasma membrane, we
will investigate the status of actin protofilaments, rescue membrane instability defect, examine
the effect of double mutation on known vertical interactions, and test direct binding of dematin
with adducin and its regulation by phosphorylation and oligomerization. (2) Dematin binds to a
protease-sensitive site on the erythrocyte plasma membrane. To identify this protein, we will
perform surface labeling of cells, immunoprecipitations, protein pull-down assays, and
proteomic analysis of erythrocyte membrane vesicles. A similar analysis will be performed for
adducin. These experiments are likley to unveil new transmembrane proteins that would tether
the junctional complex to the plasma membrane. (3) Following the strategy outlined in Aim 2, we
detected a 50 kDa erythrocyte surface protein in the immunoprecipitates of dematin. Further
analysis indicates that this protein is glucose transporter 1 (GLUT-1), a major transmembrane
receptor of the erythrocyte membrane. We propose to characterize the biochemical nature of
human dematin and adducin interactions with GLUT-1, identify the interacting domains, and
demonstrate the conservation of the new bridge in non-erythroid cells. Since dematin, adducin,
and GLUT-1 are widely expressed, including the brain, the proposed studies are potentially
significant for understanding the molecular basis of blood-brain barrier glucose transport in
normal and pathological settings such as GLUT-1 deficiency syndrome.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Erythrocyte dematin is a candidate gene for Marie Unna hereditary hypotrichosis and related hairloss disorders.
红细胞脱蛋白是 Marie Unna 遗传性少毛症和相关脱发性疾病的候选基因。
DOI:
10.1002/ajh.21153
发表时间:
2008
期刊:
American journal of hematology
影响因子:
12.8
作者:
[Mohseni,Morvarid, Chishti,AtharH]
通讯作者:
Chishti,AtharH
Calpain-1 Signaling Pathways in Platelets
-
批准号:8007400
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Calpain-1 Signaling Pathways in Platelets
-
批准号:8204714
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Regulation of Erythrocyte Glucose Transporter-1
-
批准号:7741124
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Functional Studies of Erythrocyte Dematin
-
批准号:7385699
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Calpain-1 Signaling Pathways in Platelets
-
批准号:7582882
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Regulation of Erythrocyte Glucose Transporter-1
-
批准号:8183080
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Regulation of Erythrocyte Glucose Transporter-1
-
批准号:7907804
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Calpain-1 Signaling Pathways in Platelets
-
批准号:7760140
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Regulation of Erythrocyte Glucose Transporter-1
-
批准号:8277898
-
项目类别:
-
资助金额:$40.51万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Functional Studies of Erythrocyte Dematin
-
批准号:8190965
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Regulation of Erythrocyte Glucose Transporter-1
-
批准号:8206676
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2009
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Interactions of Human Dlg Protein
-
批准号:6748407
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2002
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Interactions of Human Dlg Protein
-
批准号:6812769
-
项目类别:
-
资助金额:$15.59万
-
财政年份:2002
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Interactions of Human Dlg Protein
-
批准号:6885360
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2002
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Interactions of Human Dlg Protein
-
批准号:7057784
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2002
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Interactions of Human Dlg Protein
-
批准号:6416478
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2002
-
负责人:Athar H. Chishti
-
依托单位:
Cytoskeletal Interactions of Human Dlg Protein
-
批准号:6620377
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2002
-
负责人:Athar H. Chishti
-
依托单位:
REGULATION OF P55/HDLG INTERACTION WITH PROTEIN 4.1
-
批准号:6103032
-
项目类别:
-
资助金额:$21.93万
-
财政年份:1999
-
负责人:Athar H. Chishti
-
依托单位:
CORE FACILITY--MONOCLONAL ANTIBODY PRODUCTION
-
批准号:6103035
-
项目类别:
-
资助金额:$21.93万
-
财政年份:1999
-
负责人:Athar H. Chishti
-
依托单位:
MURINE P55 FUNCTION IN VIVO
-
批准号:6389996
-
项目类别:
-
资助金额:$29.19万
-
财政年份:1998
-
负责人:Athar H. Chishti
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: